Compare Anheuser-Busch Inbev SA (BUD) vs Freeport-McMoRan Inc (FCX) Price & Performance

Anheuser-Busch InBev (BUD) trades at $80.23, down 0.47% on the day, with technical indicators showing bearish momentum despite recent earnings beats. The company maintains solid fundamentals with $59.32B revenue, 14.9% net margin, and improving cash flow trends. Analyst consensus remains strongly positive with 57.8% buy ratings and a $90.17 price target, representing 12.4% upside potential from current levels.

BUD presents a compelling value opportunity with reasonable valuation multiples (P/E 17.07, P/S 2.54) and strong profitability metrics. Key risks include China market challenges and competitive pressures, but the company's premium brand strategy and debt reduction efforts support long-term growth prospects. The stock offers attractive total return potential for patient investors.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.